<DOC>
	<DOCNO>NCT01359384</DOCNO>
	<brief_summary>The purpose clinical trial gain substantial understanding bronchial inflammation patient severe primary immundeficiency immunoglobulin therapy . It intend characterize systemical bronchial inflammation ( IL-1 , IL-2 , IL-6 , IL-8 , IL-17 , TNF-a , NFkB , IFN-gamma , TGF-beta , TLR2 und TLR4 ) child severe immune deficiency order generate new treatment strategy base result . The method use characterization purpose within trial include specific lung function test ( spirography , bodyplethysmographie w. helium ) analysis eNO eCO . Furthermore , sputum serum sample analyze quantitative real-time polymerase chain reaction ( PCR ) , ( qRT-PCR ) cytometric bead assay ( CBA ) . Components innate immune system ( mannose-binding protein , TLR recognition protein surfactant protein ) genetically determine sputum blood respectively . In conduct study investigator retrospectively systematically evaluate available high-resolution compute tomography ( HRCT ) study affect patient .</brief_summary>
	<brief_title>Bronchial Inflammation Patients With Severe Immune Deficiency Under Immunoglobulin Treatment</brief_title>
	<detailed_description>The clinical trial contains patient collective 50 ( 6-60 year age ) shall eventually compare control group equal age gender . Both patient healthy subject recruit outpatient clinic Pediatric Allergy Pulmonology . Methods Work Programme : This study consist two study visit ( V1 V2 ) V1 : - Measurement nitric oxide expire air ( eNO ) - Measurement carbon monoxide exhale air ( eCO ) - Lung function test spirography bodyplethysmographie - Blood test : blood count , CRP , RAST , serum inflammatory mediator , genetic marker non-specific pulmonary defense system - Induced sputum inflammatory mediator microbiological investigation V2 : *Unspecific bronchial provocation test methacholine ( PD20 FEV1 metacholine )</detailed_description>
	<mesh_term>Immunologic Deficiency Syndromes</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<criteria>inform consent 6 60 year age know severe immune deficiency immunoglobulin therapy/ immune deficiency ( depend study group ) ability perform lung function test inhalation &lt; 6 &gt; 60 year age day write informed consent acute illness systemic bronchial inflammation every chronic condition infection ( e.g . HIV , tuberculosis , malignancy ) pregnancy know alcohol and/ drug abuse Inability understand extent scope study</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>May 2011</verification_date>
	<keyword>severe primary immune deficieny</keyword>
</DOC>